Prothena
PRTA
#7703
Rank
C$0.60 B
Marketcap
C$11.79
Share price
-2.14%
Change (1 day)
-16.26%
Change (1 year)

Earnings for Prothena (PRTA)

Earnings in 2026 (TTM): -C$83.32 Million

According to Prothena's latest financial reports the company's current earnings are C$54.53 Million. In 2025 the company made an earning of -C$0.27 Billion a decrease over its 2024 earnings that were of -C$0.23 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Prothena from 2012 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -C$83.32 Million-68.52%
2025 -C$0.27 Billion19.41%
2024 -C$0.23 Billion-19.09%
2023 -C$0.28 Billion45.21%
2022 -C$0.19 Billion-282.78%
2021 C$0.10 B-163.84%
2020 -C$0.17 Billion33.94%
2019 -C$0.13 Billion-44.78%
2018 -C$0.22 Billion-0.97%
2017 -C$0.23 Billion-3.33%
2016 -C$0.23 Billion99.17%
2015 -C$0.12 Billion1102.24%
2014 -C$9.54 Million-83.55%
2013 -C$57.98 Million-2.37%
2012 -C$59.39 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amarin Corporation
AMRN
-C$24.57 Million-71.39%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Alnylam Pharmaceuticals
ALNY
C$1.75 B-2,140.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Alkermes
ALKS
C$0.25 B-391.73%๐Ÿ‡ฎ๐Ÿ‡ช Ireland